Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
about
Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane reviewProtease-resistant peptide ligands from a knottin scaffold library.The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.Pancreatic polypeptide inhibits somatostatin secretion.Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.Structural genomics in endocrinology.Systematic review: the use of somatostatin or octreotide in refractory diarrhoea.Prophylactic octreotide for pancreatoduodenectomy: more harm than good?P-glycoprotein- and mrp2-mediated octreotide transport in renal proximal tubule.A semi-mechanistic model for the effects of a novel glucagon receptor antagonist on glucagon and the interaction between glucose, glucagon, and insulin applied to adaptive phase II design.Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoeaThe effect of octreotide on gastric emptying at a dosage used to prevent complications after pancreatic surgery: a randomised, placebo controlled study in volunteersPeptides and Peptide Analogs to Inhibit Protein-Protein Interactions.The expanding role of somatostatin analogs in the management of neuroendocrine tumors.Delayed gastric emptying is associated with pylorus-preserving but not classical Whipple pancreaticoduodenectomy: a review of the literature and critical reappraisal of the implicated pathomechanism.Somatostatin: Likely the most widely effective gastrointestinal hormone in the human body.Prospective randomized trial of the effect of octreotide on pancreatic juice output after pancreaticoduodenectomy in relation to histological diagnosis, duct size and leakage.Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review.New agonist- and antagonist-based treatment approaches for advanced prostate cancer.Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides.Pancreaticodigestive anastomosis and the postoperative management strategies to prevent postoperative pancreatic fistula formation after pancreaticoduodenectomy.Novel therapies for the management of short bowel syndrome in children.Postoperative ileus: mechanisms and future directions for research.Strategic approaches to optimizing peptide ADME propertiesPoly(alkyl cyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue.Variations of pharmacokinetics of drugs in patients with cirrhosis.Octreotide and enterocutaneous fistula closure in neonates and children.Site-Selective Disulfide Modification of Proteins: Expanding Diversity beyond the Proteome.Preclinical Study of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human OrgansPasireotide prevents nuclear factor of activated T cells nuclear translocation and acts as a protective agent in aminoglycoside-induced auditory hair cell loss.Effects of intra-arterial octreotide on pancreatic texture: a randomized controlled trial.Exploring new frontiers in molecular imaging: Emergence of Ga PET/CT.Blood Glucose and Insulin Concentrations after Octreotide Administration in Horses With Insulin Dysregulation.Short-bowel syndrome: an update on the therapeutic approach.Diagnosis and treatment of hyperinsulinaemic hypoglycaemia and its implications for paediatric endocrinology.Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism.Current approaches and perspectives in the therapy of medullary thyroid carcinoma.Effect of octreotide on fluid absorption and secretion by the normal human jejunum and ileum in vivo.Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.Octreotide is not effective in the acute treatment of migraine.
P2860
Q33621862-D34CCB65-53C1-40E2-AF5B-E1845032C6E9Q33912692-B2DA5E76-703D-4553-B22C-FDB8E1CB35FFQ34040492-0CB1B2E5-B624-4755-B4CE-9D109942FF9AQ34086328-02F53284-93FF-4250-8D54-A1799DFB56F0Q34119201-7D64D9C4-C09C-49C9-9F60-3E0FB08C3F4AQ34448292-3A2FC7E2-5DB0-4DCA-BC21-33AB065A3D12Q34458946-FCE7A875-95A4-4C6F-BBFD-5A34699636BCQ34548950-D824E95F-39CB-4358-A7A1-F8436C5D5194Q35041828-F94D16BB-A001-48FB-826D-333AC5B6EC3CQ35318135-8073D5F5-B7D9-411E-9FBE-0E7983CBE176Q35350975-1B3969AA-66A9-4005-9183-16EA4D62A57CQ35841392-958A6F38-1F5D-4AF6-80ED-595236E877DCQ36033291-831AE033-5BB7-43D5-9815-7A295BD4C0F0Q36347272-370CA91D-53FC-40F3-97D0-79B289A49426Q36607030-C7079A4B-57A6-4D3C-9E49-E7249CA79AACQ36724483-537C839C-C45C-4CC3-8C67-6D7A9F77EFA5Q36786182-65945C6F-0682-4DE4-8EDE-651B163F049BQ37419402-421F8608-5D38-4FF6-BB5D-4F5421392632Q38042768-7EFFDC24-4569-4C2C-8CD5-AE37CA725F7AQ38110433-99E4C4E1-E262-4994-A8BD-A605C5B80885Q38120656-F439E42E-E265-4B43-B033-80B25C2DC322Q38132622-AFF27232-94B3-480C-B691-B1DE351C7C46Q38206266-FF1D1F6C-1495-4BE1-97CB-EA1B0B41526AQ38264736-EBBB0E22-B2D1-4B17-B59F-BC2C8FEDB686Q38555292-F2D47414-E1CB-43CD-92C1-E4F07C8CA61BQ38676890-080C560B-75C2-4739-8EEF-91B60566B130Q38711920-30B0BDB0-CD54-4E6C-B6B7-E7B8AF51F353Q38990118-C4596557-9517-405A-9054-3F0EB9A1D9E9Q39140677-746C7618-0EE1-4A1B-A9A0-176F39BEDF66Q39243766-78A71167-B70B-4930-895C-BE32CC93A7C2Q39364002-3AD1E98A-2949-4C32-9B1C-AE95DCA45F0AQ39805119-667D6BFA-04C5-4E98-B03A-1D2E2F8FE9E8Q41001899-64632BDD-FF49-4F9F-A39A-B6861D949674Q41461676-62735D53-2A0D-4D08-B29B-DD31C3A68BBDQ41555063-B6198EF8-2B7C-4F2F-98E6-14DBD28D9D09Q42098360-3C76D736-CF89-42A4-93AB-5AD4FD9DC9A7Q42503835-2C9965EA-7A56-4662-9DDD-2C87ECC624C0Q42519665-14FE3804-2F3A-4492-9215-E207CE8DFBB0Q45071563-67D8ABF0-CA89-4F21-8720-BC81C72A5723Q45192198-DDFAAE1F-4E46-425F-8C93-04A9C98E0FEF
P2860
Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
@en
type
label
Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
@en
prefLabel
Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
@en
P2860
P1433
P1476
Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
@en
P2093
P2860
P356
10.1136/GUT.35.3_SUPPL.S1
P407
P433
P577
1994-01-01T00:00:00Z